Candel Therapeutics Competitors and Similar CompaniesClear all

Nektar Therapeutics's competitors and similar companies include Oncopeptides.
Nektar Therapeutics
Nektar Therapeutics
Nektar Therapeutics is a stage-clinical biopharmaceutical company.
Oncopeptides
Oncopeptides
Oncopeptides is a clinical development pharmaceutical company.
Founding Date
Founding Date
1990
Founding Date
2000
Type
Type
Public
Type
Public
Tags
Locations
Locations
San Francisco, US HQ
Hyderabad, IN
Huntsville, US
Locations
Stockholm, SE HQ
Stockholm, SE
Los Altos, US
Mountain View, US
Waltham, US
Employees
Employees
61821% increase
Employees
80
Valuation ($)
Valuation ($)
233.8 m
Valuation ($)
42.4 m

Financial

Revenue (est.)
Revenue (est.)
$55.2m (FY, 2025)
Revenue (est.)
kr71.1m (FY, 2025)
Net income
Net income
($164.1m) (FY, 2025)
Net income
(kr249.6m) (FY, 2025)
For sources of this data, please see the company profile

View Company Profiles

Oncopeptides
HQ
Stockholm, SE
Employees
80

Oncopeptides is a clinical development pharmaceutical company.

View company